Myriad Genetics (MYGN) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Price: $3.03 -4.42%
Financial Fact:
Income from continuing operations before income taxes: 4M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Income from continuing operations before income taxes: 4M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q4 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $211 million versus the consensus estimate of $213.31 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
- Stripe, Advent In Talks To Buy Paypal - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
